• Publications
  • Influence
Prognostic Factors for Cutaneous and Subcutaneous Soft Tissue Sarcomas in Dogs
TLDR
More research is needed to determine more precise estimates for recurrence rates and survival as related to completeness of surgical margins and to delineate potential differences in metastatic rate and median survival time between grades. Expand
Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
TLDR
On the basis of a low local recurrence rate and high median survival time, wide excision of tumor margins or radical surgery appeared to be an effective means for managing soft-tissue sarcomas of the trunk and extremities. Expand
Multilobular osteochondrosarcoma in 39 dogs: 1979-1993.
TLDR
Older, large-breed dogs with multilobular osteochondrosarcoma each presented primarily with a fixed mass involving the flat bones of the skull, and Histological grade, surgical margins, and tumor location affected outcome. Expand
Masitinib is safe and effective for the treatment of canine mast cell tumors.
TLDR
Masitinib is safe and effective at delaying tumor progression in dogs presenting with recurrent or nonresectable grade II or III nonmetastatic MCT. Expand
Arthroscopic subchondral bone plate microfracture technique augments healing of large chondral defects in the radial carpal bone and medial femoral condyle of horses.
TLDR
In full-thickness chondral defects in exercised horses, treatment with subchondral bone microfracture increased the tissue volume in the defects and the percentage of type II collagen in the tissue filling the defects when compared to nontreated defects. Expand
Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999).
TLDR
Results suggest that additional local treatment may not be required after complete excision of grade-II mast cell tumors and that most dogs do not require systemic treatment. Expand
Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002).
TLDR
Liver lobectomy is recommended for dogs with massive HCC because tumor-related mortality rate was 15.4 times higher in dogs in the nonsurgery group, compared with the surgery group and tumor control was excellent after surgical resection with no local recurrence and a low metastatic rate. Expand
Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study.
TLDR
Doxorubicin is an effective adjuvant to amputation in prolonging survival for dogs with appendicular osteosarcoma and as the number of mitotic figures in the biopsy increased, the risk of dying increased. Expand
Late radiation injury to muscle and peripheral nerves.
TLDR
Experimental and clinical studies have indicated that the alpha/beta ratio for muscle and peripheral nerve is approximately 4 Gy and, possibly, 2 Gy for peripheral nerve, indicating the great influence of fractionation on response of these tissues. Expand
Radiofrequency (electrosurgical) ablation of articular cartilage: a study in sheep.
TLDR
The less severe histological change in the bipolar ablative probe- treated joints compared with the shave-treated joints suggests that bipolar ablation of articular cartilage may be a better treatment for chondromalacia than the usual shaving methods of debridement. Expand
...
1
2
3
4
5
...